logo

For the Inventor, By the Inventor

Tokyo, Japan

Mitsuru Kataoka

USPTO Granted Patents = 17

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Tokyo, JA (1976 - 1978)
  • Hiromachi, JP (1978 - 1995)
  • Tokyo, JP (1990 - 1996)

Company Filing History:

goldMedal17 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1976-1996

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5580893 - Nitroxyalkylamide derivatives (1996-12-03),
2. 5378690 - New renin-inhibitory oligopeptides, their preparation and their use (1995-01-03),
3. 5378689 - Peptides having renin inhibitory activity, their preparation and use (1995-01-03),
4. 5364844 - Renin-inhibitory oligopeptides, their preparation and use (1994-11-15),
5. 5273976 - Ocular hypotensive agents (1993-12-28),
6. 5175161 - Occular hypotensive agents (1992-12-29),
7. 4914093 - Pyridazinone derivatives, their preparation and use (1990-04-03),
8. 4898862 - 1,2,4-triazinone derivatives, their preparation and use (1990-02-06),
9. 4487781 - Trihaloallyl derivatives having anti-fungal activities (1984-12-11),
10. 4421766 - Method of preserving organic materials from fungal attack and a (1983-12-20),
11. 4259350 - Iodopropargyl derivatives, their use and preparation (1981-03-31),
12. 4098893 - Pyridine derivatives and their use as anticoccidial agents (1978-07-04),
13. 4094982 - Pyridine sulfonamides and their use as anticoccidial agents (1978-06-13),
14. 4054663 - Pyridine derivatives and their use as anticoccidial agents (1977-10-18),
15. 4053608 - Compositions and methods for the treatment of coccidiosis (1977-10-11),

Title: Mitsuru Kataoka: Innovator in Renin-Inhibitory Compounds

Introduction

Mitsuru Kataoka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have renin-inhibitory activities. With a total of 17 patents to his name, Kataoka's work is vital in addressing hypertension and related health issues.

Latest Patents

One of his latest patents includes the development of Nitroxyalkylamide derivatives. These peptides exhibit renin inhibitory activity, which is crucial for the diagnosis and treatment of hypertension induced by failures in the renin-angiotensin system. The compounds he has developed are characterized by specific formulas that include various heterocyclic groups and alkyl components, showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Kataoka is currently associated with Sankyo Company, Limited, where he continues to push the boundaries of medical research and innovation. His work has not only advanced the understanding of hypertension but has also paved the way for new therapeutic options for patients suffering from this condition.

Collaborations

Throughout his career, Mitsuru Kataoka has collaborated with notable colleagues such as Yasuhiro Morisawa and Hiroyuki Koike. These partnerships have enhanced the research and development processes, leading to groundbreaking advancements in their field.

Conclusion

Mitsuru Kataoka's contributions to the pharmaceutical industry are invaluable, particularly in the area of hypertension treatment. His innovative patents and collaborative efforts continue to influence the landscape of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…